What Your Surgeon Didn't Tell You About Breast Reconstruction
- Maria Salinas

- Mar 30
- 4 min read

Breast cancer does not give women time to think. The diagnosis comes, the surgical team swoops in, and somewhere between processing a potentially terminal illness and scheduling pre-op bloodwork, a woman is expected to make one of the most permanent decisions of her life about her own body. Most surgeons present that decision as though only one answer exists. It does not.
A 2022 national survey conducted by The Harris Poll on behalf of the American Society of Plastic Surgeons found that 54 percent of women were unsure whether any surgical options beyond breast implants even existed for post-mastectomy reconstruction. More than half. In a country where this surgery has been performed for decades and where federal law has mandated insurance coverage for it since 1998, the majority of women still do not know what their choices are. That is not bad luck. That is a failure built into the standard of care.
Two established reconstruction paths exist: implant-based surgery using saline or silicone, and autologous reconstruction, which rebuilds the breast using the patient's own tissue, most commonly harvested from the abdomen. Both are legitimate. Both carry different risk profiles and long-term outcomes. And neither is the only option, because there is a third path that surgical teams routinely fail to mention at all, aesthetic flat closure, the medical term for choosing not to reconstruct a breast mound and instead surgically contouring the chest wall for a smooth, flat result.
A 2021 survey of 931 women who pursued flat closure found that 74 percent were satisfied with the outcome. Patient satisfaction with going flat is well-documented. The problem is not the procedure. The problem is that women are not being told it exists. Flat denial, defined as a surgeon's unilateral decision to disregard a patient's clearly stated preference for flat closure, leaving excess tissue behind against her wishes, is a documented and named phenomenon. In the same survey, 22 percent of respondents reported experiencing a significant level of flat denial from their surgical team. Women go into surgery having explicitly said what they want and come out of anesthesia with a body that reflects what their surgeon decided instead.
For patients who do choose reconstruction, the evidence on outcomes is worth understanding before agreeing to anything. Research published in Plastic and Reconstructive Surgery found that women who underwent autologous reconstruction reported higher breast satisfaction scores at both six weeks and six months post-surgery than women who had implants, despite beginning the process with lower baseline satisfaction and experiencing higher rates of severe complications, 27 percent compared to 12 percent for implant patients. Implants, meanwhile, are not a permanent solution. Most require monitoring and eventual replacement. Every option involves trade-offs. Women cannot weigh trade-offs they have never been told about.
Research on breast reconstruction decision-making has identified that the urgency of the timeline itself is a barrier: the compressed window between diagnosis and surgery leaves patients making major decisions while experiencing significant anxiety and distress, conditions that demonstrably limit cognitive functioning and decision-making capacity. Presenting high-stakes surgical choices to a woman who received a cancer diagnosis two weeks ago and calling that informed consent is a generous interpretation of the term.
The racial dimension of this failure is not incidental, especially in South Texas. Research drawing from cancer registries in Los Angeles and Detroit found that reconstruction rates diverged significantly along racial and ethnic lines: 40.9 percent of white patients received reconstruction, compared to 33.5 percent of Black women and only 13.5 percent of less acculturated Latinas. Less acculturated Latinas in the study were younger, less likely to hold a high school diploma, and more likely to lack health insurance than other groups, and their lower reconstruction rates persisted even after controlling for demographic and clinical factors. Language barriers, reduced access to plastic surgery referrals, and physicians who simply did not raise the subject all contributed to those numbers. The disparity is not explainable by medical factors alone.
The insurance picture is more complicated than most women realize, and significantly less airtight than it sounds. The Women's Health and Cancer Rights Act, signed in October 1998, requires most group health plans and insurance companies that cover mastectomies to also cover breast reconstruction. That mandate includes all stages of reconstruction on the affected breast, surgery on the opposite breast for symmetry, prostheses, and treatment for physical complications including lymphedema. Insurers are legally required to notify patients of this coverage at enrollment and every year after. Despite that, 73 percent of women remain uncertain whether they would be personally responsible for paying reconstruction costs.
Self-funded short-term plans, certain government health plans, and plans sponsored by religious organizations are exempt from the law's requirements. Medicare and Medicaid are also exempt. Employers who are churches, state agencies, or local school districts operating self-insured plans can opt out of coverage entirely. In the Rio Grande Valley, where school districts and county governments rank among the region's largest employers, those exemptions fall squarely on the population already least likely to receive comprehensive surgical counseling.
A woman receiving inadequate information in a hospital is not experiencing an anomaly. She is experiencing the cumulative result of a medical system that has spent decades treating informed consent as a procedural checkbox rather than an actual obligation and a legal framework with enough carve-outs to let the most vulnerable patients slip through without anyone being technically in the wrong.
@Santitos
@salinasmariasantos
Copyright © 2026 Maria Santos Salinas for FRONTeras.
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission. Sharing the original posts or links from FRONTeras on social media is allowed and appreciated.
FRONTeras is an independent publication protected by the First Amendment's guarantees of freedom of speech and freedom of the press. Our reporting and commentary draw from documented facts, public records, court filings, and reliable news sources. Opinions expressed in editorials are solely those of the author and do not constitute legal advice, divine truth, or the official position of FRONTeras. All articles, whether news, satirical or commentary, are produced according to journalistic standards of accuracy, fairness, and independence. While errors in reporting are possible, they will be corrected promptly once verified with credible sources. Critiques are grounded in evidence, not malice. Attempts to censor, intimidate, or punish the press will not alter the facts we publish. FRONTeras will continue to report without fear or favor.
Comments